If you are interested in knowing more about our in Silico Human Drug Safety and Efficacy project, join our mailing list! You will receive our periodic newsletter, with news and information on upcoming events and recent publications.
Send a blank email to email@example.com
We will only use your data (email address) to send you information about our “In Silico Human Drug Safety and Efficacy” project, in accordance with the General Data Protection Regulation (GDPR). You can consult our Privacy Notice here.
Send a blank email to firstname.lastname@example.org